Ytracis (yttrium [90Y] chloride)
- Region
- 🇪🇺 EU
- Active substance
- yttrium [90Y] chloride
- Company
- CIS bio international
- Status
- Withdrawn
- Therapeutic area
- Radionuclide Imaging
- EU approval
- Mon 24 Mar 2003
- Application
- EMEA/H/C/000460
- ATC
- V09
- Official record
- www.ema.europa.eu
Indication
To be used only for the radiolabelling of carrier molecules which have been specifically developed and authorised for radiolabelling with this radionuclide.Radiopharmaceutical precursor - Not intended for direct application to patients.
Regulatory milestones
No milestones recorded in the last year.
Same substance in other markets
- 🇪🇺 Yttriga Authorised · Eckert Ziegler Radiopharma GmbH
- 🇪🇺 Theryttrex Withdrawn · MDS Nordion S.A.
Follow Ytracis
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.